SCHEMBL7364520

SCHEMBL7364520

CCOC(=O)c1coc2c1C(=O)N(CC)CC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.40
ALDH1A1 P00352 6/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
TSHR P16473 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HTT P42858 1/20 0.36
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
GAA P10253 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34
HPGD P15428 1/20 0.34
MAPT P10636 3/20 0.34
BAZ2B Q9UIF8 1/20 0.34
BAZ2A Q9UIF9 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM1 P11229 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7371057 0.76 BRD4 (0.44) MAOBALDH1A1TSHRMEN1KMT2A
SCHEMBL4899883 0.76 BRD4 (0.47) MAOBALDH1A1TSHRMEN1KMT2A
SCHEMBL7392509 0.74 GABRA1 (0.41) ALDH1A1L3MBTL1TSHRMEN1KMT2A
SCHEMBL16931455 0.73 MAOB (0.41) MAOBALDH1A1L3MBTL1TSHRMEN1
SCHEMBL6773220 0.68 MAOB (0.42) MAOBALDH1A1L3MBTL1TSHRMEN1
SCHEMBL16931454 0.68 MAOB (0.38) MAOBALDH1A1L3MBTL1TSHRMEN1
SCHEMBL16931216 0.68 MAOB (0.41) MAOBALDH1A1L3MBTL1TSHRMEN1
SCHEMBL16931319 0.66 MAOB (0.40) MAOBALDH1A1L3MBTL1TSHRMEN1
SCHEMBL2564191 0.66 KCNK3 (0.40) ALDH1A1L3MBTL1TSHRKDM4EHPGD
SCHEMBL28017211 0.65 BAZ2B (0.46) ALDH1A1L3MBTL1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6096887-A USEFUL IN THE DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND FOR ENHANCEMENT OF MEMORY. NEUROGEN CORPORATION (US) 2000-08-01 US disclosed
US-5925770-A GAMMA-AMINOBUTYRIC ACID DERIVATIVES FOR DIAGNOSIS OR TREATMENT OF ANXIETY, SLEEP DISORDERS, SEIZURES, OVERDOSES OF BENZODIAZEPINE TYPE DRUGS, COGNITION ACTIVATORS NEUROGEN CORPORATION (US) 1999-07-20 US disclosed
US-5750702-A Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands NEUROGEN CORPORATION (US) 1998-05-12 US disclosed
WO-1998002420-A9 CERTAIN FUSED PYRROLECARBOXANILIDES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS 1998-04-23 WO disclosed
US-5723462-A SLEEP AND SEIZURE DISORDERS; COGNITION ACTIVATORS, ANXIOLYTIC AGENTS NEUROGEN CORPORATION (US) 1998-03-03 US disclosed